Welcome and introduction
Topic:
Diabetes and the Heart
Speaker:
Professor T. Luescher (London, GB)
Sponsored by The Boehringer Ingelheim, Eli Lilly and Company Alliance
Event:
ESC Congress 2019
Congress Presentation
4 more presentations in this session
The role of SGLT2 inhibitors in CV risk reduction in patients with type 2 diabetes
Speaker: Professor S. Kaul (Los Angeles, US)
Taking the initiative: the cardiologist´s perspective
Speaker: Professor N. Marx (Aachen, DE)
The SGLT2 inhibitor era: what more can we expect?
Speaker: Professor S. Anker (Berlin, DE)
Audience questions and answers, summary and close
Speaker: Professor T. Luescher (London, GB)
Access the full session
About the event
